高氧致慢性肺疾病早产鼠肺组织CDK4 p21的表达及意义被引量：1

Expression and roles of CDK4 and p21 in lung tissues of premature rats with hyperoxia-induced chronic lung disease

导出

摘要目的早产儿慢性肺疾病（CLD）的发病机制目前研究还不十分清楚，但CLD的最终病理变化与肺细胞增殖有关。该文采用高氧诱导早产鼠CLD模型为对象，探讨CDK4和p21基因动态表达与肺细胞增殖调控的关系。方法高浓度氧致早产鼠CLD模型（实验组）和正常对照组各40例为研究对象，每组分别于实验后的1，3，7，14和21d随机选取8只大鼠处死，取出肺组织，常规制成5μm切片。检测观察：①肺组织形态学；②肺组织纤维化评分；③采用免疫组化检测肺组织内PCNA表达；④采用原位杂交检测肺组织CDK4mRNA和p21mRNA的表达。结果两组肺组织细胞PCNA指数：与对照组比较，实验组1d，3dPCNA表达均减弱（P〈0．05），7d开始表达增强（P〈0．01），14d和21d明显高于对照组（P〈0．01）。两组肺组织细胞CDK4mRNA表达强度：从7d开始实验组高于对照组（P〈0．05），14d，21d明显高于对照组（P〈0．01）。两组肺组织细胞p21mRNA表达强度：实验组1d，3d表达明显高于对照组（P〈0．01），7d后持续下降，但也高于对照组（P〈0．05）。7-21d肺组织细胞CDK4 mRNA，p21mRNA表达分别与PCNA呈显著正、负相关（r分别为0．83和-0．81，P〈0.05）。结论高氧可诱导早产鼠肺细胞增殖。肺组织细胞CDK4基因的过度表达、p21基因的表达下降，可能是高氧诱导肺细胞增殖的机制之一。 Objective The pathogenic mechanisms of chronic lung disease （CLD） of premature infants are not fully understood. Its final pathological changes have been shown to relate with lung cell proliferation. The aim of the study was to explore the relationship of the expression of cyclin dependent kinase 4 （CDK4） mRNA and cyclin dependent kinase inhibitor （CDKI） p21 mRNA with lung cell proliferation. Methods Eighty premature rats were randomly assigned to a hyperoxia group and a control group （n = 40 each）. The hyperoxia group was exposed to high concentration of oxygen （FiO2 〉 0.90）and developed CLD. The control group was exposed to room air （FiO2 = 0.21 ）. The rats were randomly subdivided into groups sacrificed at 1,3, 7, 14 and 21 days of exposure. Lung tissues were collected and made into 5μm sections. Expression of proliferating cell nuclear antigen （PCNA） in lung tissues was detected by immunohistochemistry. Dynamic expression of CDK4 mRNA and p21 mRNA were detected by in situ hybridization. Lung histomorphology and fibrosis were observed by microscopy. Results Expression of PCNA and CDK4 mRNA of lung cells in the hyperoxia group increased significantly after 7 days of exposure, and further increased after 14 and 21 days compared with controls, p21 mRNA expression in the hyperoxia group significantly increased after 1 and 3 days of exposure. After 7 days, p21 mRNA expression progressively decreased, but remained at a higher level than control through 21 days of exposure. PCNA expression was positively correlated to CDK4 mRNA expression （ r = 0.83, P 〈 0. 05 ） and negatively correlated to p21 mRNA expression （r = -0.81, P 〈 0.05 ）in the hyperoxia group between 7 and 21 days of exposure. Conclusions Hyperoxia can induce lung cell proliferation in premature rats. The over-expression of CDK4 gene and the decreased expression of p21 gene in lung tissues may be associated with lung cell proliferation induced by hyperoxia.

作者高英薛辛东李津阳王妮

机构地区中国医科大学附属第二医院儿科沈阳市妇婴医院儿科

出处《中国当代儿科杂志》 CAS CSCD 2007年第6期595-600,共6页 Chinese Journal of Contemporary Pediatrics

关键词高氧慢性肺疾病早产肺细胞细胞增殖大鼠 Hyperoxia Chronic lung disease Lung cell Cell proliferation Premature rats

分类号 R722.6 [医药卫生—儿科]

引文网络
相关文献

参考文献23

1Cederqvist K, Sorsa T, Tervahartiala T, Maisi P, Reunanen K, Lassus P, et al. Matrix metalloproteiinases-2, -8, and-9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress [J]. Pediatrics, 2001, 108(3) :686-692.
2O'Reilly MA, Stavensky RJ, Watkins RH, Reed CK, de Mesy Jensen KL, Finkelstein JN, et al. The cyclin-dependent kinase inhibitor p21 protects the lung from oxidatine stress[ J]. Am J Respir Cell Mol Biol, 2001, 24(6) :703-710.
3Radomski A, Sawicki G, Olson DM, Radomski MW. The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats[ J]. Br J Pharmacol, 1998, 125(7) :1455-1465.
4Kenyon NJ, Ward RW, McGrew G, Last JA. TGF-β1 causes airway fibrosis and increased collagen Ⅰ and mmRNA in mice [J]. Thorax, 2003, 58(9) :772-777.
5富建华,薛辛东.高氧诱导早产鼠慢性肺疾病肺超微结构变化及氧化应激反应的研究[J].中国当代儿科杂志,2004,6(1):23-26. 被引量：15
6Tashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale [ J ]. J Clin Pathol, 1988, 41 (2) :467-470.
7Jobe AH, Banealari E. Bronehopulmonary dysplasia [ J ]. Am J Respir Cfit Care Med, 2001, 163(7) :1723-1729.
8American Cademy of Pediatrics, Committee on Fetus and Newborn. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants [J].Pediatrics, 2002, 109(2) :330-338.
9刘雪雁,赵晓东,薛辛东.持续吸入高浓度氧对新生大鼠肺的影响[J].中国优生与遗传杂志,2004,12(6):78-79. 被引量：4
10Hall PA, Levison DA, Woods AL, Yucc, Kellock DB, Watkins JA, et al. Proliferating cell nuclear antigen immulocalization in paraffin in section : an index of cell proliferation with evidence deregulated expression in some neoplasms[J]. J Pathol, 1990, 162 (4) :285-293.

二级参考文献13

1Massaro D, Teich N, Massaro GD. Postnatal development of pulmonary alveoli:modulation in rats by thyroid hormones[J]. Am J Physiol, 1986, 250(1 Pt 2):R51-55.
2Cederqvist K, Sorsa T, Tervahartiala T, et al. Matrix metalloproteinases-2, -8, and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress[J]. Pediatrics, 2001, 108(3): 686-92.
3Ohki Y, Kato M, Kimura H, et al. Elevated type IV collagen in bronchoalveolar lavage fluid from infants with bronchopulmonary dysplasia[J]. Biol Neonate, 2001, 79(1):34-38.
4Cherukupalli K, Larson JE, Rotschild A, et al. Biochemical, clinical, and morphologic studies on lungs of infants with bronchopulmonary dysplasia[J]. Pediatr Pulmonol, 1996, 22(4): 215-29.
5Schrod L, Neuhaus T, Speer CP, et al. Possible role of uric acid as an antioxidant in premature infants[J]. Biol Neonate, 1997,72:102-111.
6Janine YK, Stephen MB. Developmental changes in murine brain antioxidant enzymes[J]. Pediatric Research, 2003, 54(1):77-82.
7Yeshin H, Margaret S, James D, Crapo. Antioxidant enzyme expression in rat lung during hyperoxia[J]. Am J Physiol,1996,270:L810-L818.
8Schock BC, Sweet DG, Ennis M, et al. Oxidative stress and increased type-IV collagenase levels in bronchoalveolar lavage fluid from newborn babies[J]. Pediatr Res,2001,50(1):29-33.
9Saugstad OD. Chronic lung disease: oxygen dogma revisited[J]. Acta Pediatr, 2001,90(1):113-115.
10Davis J, Rosenfeld W, Parad R. Improved pulmonary outcome at one year corrected age in premature neonates treated with recombinant human superoxide dismutase[J]. Pediatr Res, 2000,47(3):395A.